LY-156758

Known as: LY 156758, LY156758 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1983-2002
02419832002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Polychlorinated biphenyls (PCBs) are ubiquitous environmental contaminants whose effects on biological systems depend on the… (More)
Is this relevant?
1996
1996
Estrogen or raloxifene (LY156758) prevent estrogen deficiency-induced bone loss in animals and humans. We demonstrated in the rat… (More)
Is this relevant?
1990
1990
Estrogen-responsive proliferation in the MCF-7 cell line was used as a bioassay for detection of dietary estrogens. The bioassay… (More)
Is this relevant?
1988
1988
Fourteen patients with disseminated breast cancer with primary or secondary resistance to tamoxifen were treated with LY156758… (More)
Is this relevant?
Highly Cited
1986
Highly Cited
1986
We have examined the effect of androst-5-ene-3 beta,17 beta-diol (delta 5-diol) and its precursors, dehydroepiandrosterone (DHEA… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Endocrine therapy with estrogen deprivation or with antiestrogens results in tumor regression in a subset of patients with… (More)
Is this relevant?
1984
1984
In an effort to prepare nonsteroidal antiestrogens demonstrating greater antagonism and less intrinsic estrogenicity than those… (More)
Is this relevant?
1984
1984
MCF-7 human breast cancer cells secrete two immunologic types of plasminogen activator, one related to urokinase, the other… (More)
Is this relevant?
1984
1984
A new benzothiophene-derived antiestrogen (LY156758) when orally administered was well absorbed in rats and monkeys while approx… (More)
Is this relevant?
1983
1983
Keoxifene (LY156758) is a new benzothiophene-derived antiestrogen with an extremely low degree of estrogenicity. Administration… (More)
Is this relevant?